Background Outcomes of radical prostatectomy (RP) in men with history of lower urinary
tract symptoms related to benign prostatic enlargement (LUTS/BPE) surgery represents a …

Background: This study aimed to explore the prevalence and clinical risk factors in patients
diagnosed with incidental prostate cancer (IPC) during certain surgeries (transurethral …

Abstract Background Data regarding North-American incidental (cT1a/b) prostate cancer
(PCa) patients is scarce. To address this, incidental PCa characteristics (age, PSA values at …

Introduction This systematic review aims at reporting the incidence, predictive factors, and
the oncological outcomes of incidental prostate cancer (IPCa) in men who underwent …

Prostate cancer can be detected incidentally after surgical therapy for benign prostatic
obstruction such as holmium laser enucleation of the prostate (HoLEP), thus called …

Despite the innovations made to enhance smarter screening and conservative management
for low-grade prostate cancer, overdiagnosis, and overtreatment remains a major health …

Background and objective Patients diagnosed with grade group (GG) 1 prostate cancer
(PCa) following treatment for benign disease (“incidental” PCa) are typically managed with …

Purpose: Approximately 1 in 10 patients without prior prostate biopsy undergoing surgery for
lower urinary tract symptoms harbor incidental prostate cancer, however, practice guidelines …

Objectives To describe the incidental prostate cancer (iPCa) rate and identify predictive
factors for PCa progression after holmium laser enucleation of the prostate (HoLEP) …

Purpose Despite advancements in prostate multiparametric magnetic resonance imaging
(mpMRI) and fusion biopsy (FB), the management of incidental prostate cancer (IPCa) after …